Steven Wheen
Stock Analyst at Jarden
(3.87)
# 1,940
Out of 4,676 analysts
239
Total ratings
47.4%
Success rate
8.3%
Average return
Main Sectors:
Stocks Rated by Steven Wheen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RHC Ramsay Health Care Limited | Maintained: Buy | $47.60 | $44.36 | +7.30% | 28 | Aug 24, 2026 | |
| ASX: REG Regis Healthcare Limited | Maintained: Hold | $7.50 | $6.07 | +23.56% | 17 | Aug 24, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $21.10 → $20.70 | $16.16 | +28.09% | 31 | Aug 21, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $22.30 → $22.90 | $20.44 | +12.04% | 30 | Aug 21, 2026 | |
| ASX: HLS Healius Limited | Upgraded: Hold | $0.47 → $0.50 | $0.43 | +17.65% | 33 | Aug 20, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $169.00 → $165.00 | $137.84 | +19.70% | 17 | Aug 19, 2026 | |
| ASX: CSL CSL Limited | Upgraded: Buy | $191.00 → $207.00 | $173.64 | +19.21% | 34 | Aug 19, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $40.20 → $39.90 | $32.51 | +22.73% | 23 | Aug 10, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.35 → $3.25 | $2.40 | +35.42% | 23 | Feb 25, 2026 | |
| ASX: QBE QBE Insurance Group Limited | Maintained: Hold | $22.00 | $22.05 | -0.23% | 1 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.71 → $0.75 | $0.57 | n/a | 2 | Nov 27, 2024 |
Ramsay Health Care Limited
Aug 24, 2026
Maintained: Buy
Price Target: $47.60
Current: $44.36
Upside: +7.30%
Regis Healthcare Limited
Aug 24, 2026
Maintained: Hold
Price Target: $7.50
Current: $6.07
Upside: +23.56%
Telix Pharmaceuticals Limited
Aug 21, 2026
Maintained: Buy
Price Target: $21.10 → $20.70
Current: $16.16
Upside: +28.09%
Sonic Healthcare Limited
Aug 21, 2026
Maintained: Hold
Price Target: $22.30 → $22.90
Current: $20.44
Upside: +12.04%
Healius Limited
Aug 20, 2026
Upgraded: Hold
Price Target: $0.47 → $0.50
Current: $0.43
Upside: +17.65%
Cochlear Limited
Aug 19, 2026
Maintained: Hold
Price Target: $169.00 → $165.00
Current: $137.84
Upside: +19.70%
CSL Limited
Aug 19, 2026
Upgraded: Buy
Price Target: $191.00 → $207.00
Current: $173.64
Upside: +19.21%
ResMed Inc.
Aug 10, 2026
Maintained: Buy
Price Target: $40.20 → $39.90
Current: $32.51
Upside: +22.73%
Integral Diagnostics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $3.35 → $3.25
Current: $2.40
Upside: +35.42%
QBE Insurance Group Limited
Feb 20, 2026
Maintained: Hold
Price Target: $22.00
Current: $22.05
Upside: -0.23%
Nov 27, 2024
Maintained: Hold
Price Target: $0.71 → $0.75
Current: $0.57
Upside: n/a